ECM29 is a highly conserved protein that plays a pivotal role in the regulation of proteasome assembly and function, acting as a key component in the cellular machinery responsible for protein degradation and turnover. It serves as a scaffold protein, facilitating the correct assembly and stabilization of the proteasome complex, an essential element in the ubiquitin-proteasome system. By binding to both the 20S core particle and the 19S regulatory particle, ECM29 ensures the efficient degradation of ubiquitinated proteins, thereby maintaining cellular homeostasis and responding to stress conditions. This protein is involved in various cellular processes, including cell cycle control, apoptosis, and the stress response, by regulating the proteolytic activity of the proteasome. Its function is critical for the removal of misfolded, damaged, or regulatory proteins, thus safeguarding the cell's proteomic integrity and contributing to the regulation of numerous signaling pathways.
The activation of ECM29 and its subsequent engagement in proteasome regulation can be influenced by several mechanisms, primarily through post-translational modifications and interactions with other cellular components. Phosphorylation, ubiquitination, and sumoylation of ECM29 can modulate its ability to bind to the proteasome, affecting the assembly, disassembly, and substrate specificity of the complex. These modifications act as molecular switches, altering ECM29's conformation and its interaction affinity with the proteasome, thereby fine-tuning the proteolytic capacity of the cell according to the prevailing cellular conditions. Additionally, ECM29's function and activation are modulated through its interaction with other regulatory proteins and co-factors, which can enhance or inhibit its scaffold activity. This complex regulatory network ensures that ECM29-mediated proteasome assembly and function are precisely controlled, enabling the cell to efficiently respond to both internal and external cues. Through these mechanisms, ECM29 plays a critical role in maintaining cellular homeostasis, regulating protein turnover, and facilitating the cell's adaptation to stress, thereby underscoring its importance in cellular physiology and the dynamic regulation of proteasome activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor that can indirectly influence the binding of ECM29 to the proteasome. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
Another proteasome inhibitor; can support ECM29's interaction with proteasomes. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor, it can indirectly modify the dynamics of ECM29 in the cell. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
Inhibits the proteasome and can influence ECM29 indirectly. | ||||||
Carfilzomib | 868540-17-4 | sc-396755 | 5 mg | $41.00 | ||
Proteasome inhibitor; can modulate the activity associated with ECM29. | ||||||
IU1 | 314245-33-5 | sc-361215 sc-361215A sc-361215B | 10 mg 50 mg 100 mg | $138.00 $607.00 $866.00 | 2 | |
Inhibitor of USP14, a proteasome-associated deubiquitinase; can indirectly affect ECM29. | ||||||
NMS-873 | 1418013-75-8 | sc-478803 | 5 mg | $300.00 | ||
VCP/p97 inhibitor which can affect proteasomal degradation; indirect effect on ECM29. | ||||||
Ixazomib | 1072833-77-2 | sc-489103 sc-489103A | 10 mg 50 mg | $311.00 $719.00 | ||
Proteasome inhibitor; can influence ECM29 indirectly. | ||||||
Oprozomib | 935888-69-0 | sc-477447 | 2.5 mg | $280.00 | ||
Another proteasome inhibitor, influencing the dynamics of ECM29. | ||||||
ONX 0914 | 960374-59-8 | sc-477437 | 5 mg | $245.00 | ||
Inhibitor of the immunoproteasome subunit LMP7, can indirectly influence ECM29. | ||||||